Zenotech Laboratories Limited is an India-based pharmaceutical company operating out of Hyderabad, India. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products.
Symbiotec is a research-driven, science-based pharmaceutical and biotechnology company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients (APIs). With over 30 years of industry expertise, we have evolved from a Lab-Scale Steroid manufacturer into a fully integrated global platform.
USV Private Limited is a prominent Indian multinational pharmaceutical and biotechnology company founded in 1961, specializing in diabetes and cardiovascular therapeutics.
Researchers have identified a key biological mechanism responsible for the poor prognosis seen in a subset of patients with diffuse large B-cell lymphoma (DLBCL), the most common aggressive form of lymphoma worldwide. In a new study published in Nature Genetics, an international team led by Goethe University Frankfurt, Universitätsmedizin Frankfurt, the German Cancer Consortium (DKTK), and the Frankfurt Cancer Institute discovered novel molecular features that can distinguish high-risk patients who are unlikely to respond to standard first-line treatment.
Glenmark Pharmaceuticals Inc., USA, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited, has announced the launch of Olanzapine for Injection, 10 mg/vial, Single-Dose Vial in the United States. The newly launched product is bioequivalent and therapeutically equivalent to Zyprexa® IntraMuscular Injection 10 mg/vial (NDA 021253) marketed by Cheplapharm Registration GmbH.
A new scientific review has highlighted the growing potential of liquid biomarkers to transform the early detection, diagnosis, and treatment monitoring of colorectal cancer (CRC), offering a less invasive alternative to traditional screening methods such as colonoscopy.